Company Filing History:
1 out of 832,880 Years Active: 2021
Title: Innovations by Inventor Anna Krotkova in Therapeutic Composition
Introduction: Anna Krotkova is a prominent inventor based in Moscow, Russia, recognized for her significant contributions to the medical field through innovative therapeutic compositions. With one patent to her name, Krotkova has developed a unique approach to treating conditions related to human IL-1β modulation.
Latest Patents: Anna Krotkova holds a patent for a Human IL1-R1 derived inhibitor of IL-1β. This groundbreaking invention describes a therapeutic composition that can be utilized for the treatment or prevention of diseases associated with the modulation of human IL-1β activity. The invention centers around the engineering of a heterodimeric protein assembly, which binds to human IL-1β and reduces its function. This innovative assembly includes extracellular portions of human IL1-R1 and human IL-1RAcP, or their functional fragments, each fused to distinct mutants of the Fc portion of human Ig Gamma-1. The design promotes heteromeric dimer formation between the Fc mutants, ensuring effective therapeutic application in humans and animals.
Career Highlights: Anna Krotkova’s invention represents a significant advancement in biomedical engineering, particularly in the realm of immunotherapy. Her ability to combine elements of protein engineering with therapeutic applications underscores her innovative thinking and dedication to improving health outcomes.
Collaborations: Throughout her career, Anna has collaborated with esteemed colleagues such as Yan Lavrovsky and Ting Xu. These partnerships have fostered a dynamic exchange of ideas, enhancing the development and application of her patented technology in the medical field.
Conclusion: With her innovative approach and collaborative efforts, Anna Krotkova has made a notable impact in the development of therapies combating diseases linked to IL-1β activity. Her work not only exemplifies ingenuity in the scientific community but also represents a promising advancement in therapeutic compositions for human and animal health.